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112Objective: We sought to evaluate the effectiveness of aortic valve replacement for reducing gastrointestinal
bleeding in patients with Heyde syndrome, in whom gastrointestinal bleeding is associated with intestinal an-
giodysplasia and aortic valve stenosis.
Methods:We conducted a retrospective review of patients treated at theMayo Clinic between 1971 and 2007 for
gastrointestinal bleeding and intestinal angiodysplasia who later underwent aortic valve replacement for severe
aortic valve stenosis. We analyzed early and late outcomes, including recurrent gastrointestinal hemorrhage.
Results: Fifty-seven patients (39 men and 18 women) were identified. At operation, the median age of patients
was 75 years. Intestinal angiodysplasia occurred most commonly in the duodenum and right side of the colon.
Before aortic valve replacement, the mean number of bleeding episodes was 12 per patient-year; 48 patients
(84%) required blood transfusions. Bioprosthetic valves were used in 47 patients. During follow-up extending
to 15 years, 45 patients (79%) had no recurrence of bleeding. In patients who experienced recurrent bleeding, the
episodes were reduced from a mean  standard deviation of 4.7  7 episodes per patient-year to 1.9  2 per
patient-year. Recurrent bleeding occurred only in patients with lesions of the duodenum or right colon. Among
patients who received bioprostheses, the overall risk of recurrent bleeding was 15%, lower than the 50% risk of
subsequent gastrointestinal bleeding with mechanical prostheses.
Conclusions: Aortic valve replacement seems to decrease the risk of gastrointestinal bleeding in patients with
Heyde syndrome and is curative in approximately 80%. Although rates of recurrent bleeding were not signif-
icantly different between the 2 prosthetic valve types, the higher risk of bleeding in patients receiving warfarin
makes bioprosthetic valves the valve of choice for most patients. (J Thorac Cardiovasc Surg 2012;144:112-6)The association of aortic valve stenosis with gastrointestinal
(GI) bleeding was first described by Edward Heyde in
1958.1 Since then, at least 39 publications in the medical lit-
erature have linked aortic valve stenosis to GI bleeding, but
most of these articles are anecdotal case reports.2 The
source of bleeding in patients with Heyde syndrome has
been attributed to intestinal angiodysplasia.3 Angiodyspla-
sia is a well-known source of GI bleeding, accounting for
1% to 6% of patients hospitalized for GI bleeding and
for 30% to 40% of those with obscure bleeding originating
in the small bowel.4,5 As is true for calcific aortic valve
stenosis, the incidence of angiodysplasia increases with
age,6 and the 2 entities combined may increase the risk
for GI bleeding 100-fold.7
Several observations have given rise to theories about the
possible mechanisms linking aortic valve stenosis, GI
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The Journal of Thoracic and Cardiovascular Surgof intestinal angiodysplasia is increased in patients who
have traditional cardiovascular risk factors for acquired aor-
tic valve stenosis.8-10 Second, the concomitant appearance
of aortic valve stenosis and intestinal angiodysplasia in
elderly patients may be explained by age-dependent tissue
degeneration.11 Age-related changes in intestinal microcir-
culation may lead to reduced GI perfusion, hypoxemia-
induced dilation of blood vessels, and acceleration in the
rate of development of intestinal angiodysplasia.8 Also,
GI hypoxemia may increase the vulnerability of the mucosa
to local bleeding.12 Finally, recent evidence has shown that
an acquired type of von Willebrand syndrome (type 2A) is
common in patients who have aortic valve stenosis, and it
predisposes these patients to bleeding.13 Sucker14 proposed
a unifying concept that stresses the multifactorial pathogen-
esis of Heyde syndrome. He hypothesized that the combina-
tion of disturbed integrity in the GI mucosa and an acquired
hemostatic defect in patients with aortic valve stenosis pre-
disposes these patients to GI bleeding.
Correction of aortic valve stenosis with aortic valve re-
placement (AVR) seems to decrease the risk of the GI bleed-
ing. For patients with Heyde syndrome, AVR has been
shown to reduce the risk of recurrent bleeding more so
than bowel surgery15 and may result in its complete cessa-
tion.12,16,17 Resolution of von Willebrand syndrome has
been demonstrated after AVR.18,19 The objective of theery c July 2012
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AVR ¼ aortic valve replacement
GI ¼ gastrointestinal
SD ¼ standard deviation
Thompson et al Acquired Cardiovascular Diseasepresent study was to review the experience with Heyde
syndrome at the Mayo Clinic and to determine to what
extent AVR reduced the risk of further GI bleeding.FIGURE 1. Preoperative versus postoperative GI bleeding. In 12 pa-
tients with persistent GI bleeding after AVR, the mean  SD number
of bleeding episodes per patient-year was reduced from 4.7  7 to
1.9  2. Graph shows only 10 lines because 2 patients had the same num-
ber of preoperative and postoperative bleeding events as 2 other patients.
GI, Gastrointestinal.
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After approval of our study protocol by the institutional review board,
we conducted a retrospective review of Mayo Clinic medical records for
the period between January 1973 and December 2007 to identify patients
aged 18 years or more who had experienced a GI bleeding episode and,
at a later date, had undergone AVR for severe aortic valve stenosis. Severe
aortic valve stenosis was defined as an aortic valve area less than 1 cm2 or
a mean gradient greater than 40 mm Hg, as determined by Doppler echo-
cardiography. Patients were excluded from analysis if they had a known
cause of GI bleeding, such as ulcer or cancer. Data were collected by chart
review. Follow-up was obtained by chart review and a questionnaire mailed
to surviving patients.
Categoric data, expressed as percentages, were compared using the chi-
square test, as appropriate. Continuous variables, expressed as mean 
standard deviation (SD) or median values, were compared using the
2-sample Wilcoxon rank-sum test. Postoperative freedom-from-event
curves were estimated using theKaplan–Meiermethod. Baseline predictors
of subsequent GI bleeding were identified by univariate Cox proportional
hazards analysis. Variables univariately significant on the basis of a thresh-
old value ofP less thanor equal to .15were entered stepwise into amultivari-
able logistic regression model to confirm independent predictive value.TABLE 2. Diagnostic methods used to document intestinal
angiodysplasia in 57 patients
Patients undergoing eachRESULTS
Between January 1973 and December 2007, 57 consecu-
tive patients (39 male) with Heyde syndromewere treated at
our tertiary care academic medical center. All patients had
GI bleeding before AVR and had been given a diagnosis
of intestinal angiodysplasia. Melena was the presenting
sign of GI bleeding in 30 patients (53%). Other presenta-
tions of bleeding included hematochezia, anemia, or
a guaiac-positive stool sample (Table 1). Twenty-two pa-
tients (39%) had hemoglobin less than 10 mg/dL at initial
presentation for GI bleeding. Before AVR, the mean 
SD number of documented episodes of GI bleeding perTABLE 1. Presentation of gastrointestinal bleeding in 57 patients
before aortic valve replacement
Sign/symptom at presentation Patients, no. (%)*
Melena 30 (53)
Anemia 12 (21)
Occult blood in stooly 7 (12)
Hematochezia 4 (7)
Abdominal discomfort 2 (4)
Hemoptysis 2 (4)
*Percentages total more than 100% because of rounding. yBy guaiac-positive stool.
The Journal of Thoracic and Capatient was 4  6 (range, 1–27), and the mean number of
bleeding episodes per patient-year was 12 (Figure 1).
Forty-eight patients (84%) received blood transfusions,
with a median of 9 units of packed red cells transfused
(range, 0–40 units). The mean length of time from initial di-
agnosis of GI bleeding to AVR was 19  33 months.
Before AVR, patients frequently underwent multiple in-
vestigations to try to identify the cause of the GI bleeding
and the location of the intestinal angiodysplasia (Table 2).
Esophagogastroduodenoscopy was performed in 51 pa-
tients (89%), making it the most commonly used diagnostic
method. Most patients underwent at least 2 esophagogastro-
duodenoscopies (range, 0–8) before the location of the in-
testinal angiodysplasia was determined. The second most
common type of study was colonoscopy, which was per-
formed 64 times in 41 patients. Thirty-five (61%) of the
57 patients underwent both procedures.
Before undergoing AVR, all 57 patients had received a di-
agnosis of intestinal angiodysplasia, which was most often
identified in the right colon but was also found throughoutType of procedure procedure, no. (%)*
EGD 51 (89)
Colonoscopy 41 (72)
Upper GI swallow study 27 (47)
Barium enema 17 (30)
Angiography 13 (23)
Tagged red blood cell scan 7 (12)
Exploratory laparotomy 5 (9)
EGD, Esophagogastroduodenoscopy. *Most patients had more than 1 type of proce-
dure or had repeat procedures (eg, 2 EGDs). Numbers indicate howmany patients had
at least 1 procedure of the type listed but do not reflect repeat procedures in the same
patient.
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TABLE 3. Locations of intestinal angiodysplasia in 57 patients
Location Patients, no. (%)*
Right colon 16 (28)
Jejunum 14 (25)
Right colon and another GI tract location 12 (21)
Duodenum 9 (16)
Left colon 4 (7)
Stomach 2 (4)
*Percentages total more than 100% because of rounding.
TABLE 4. Multivariate analysis of risk factors for recurrent
gastrointestinal bleeding after aortic valve replacement
Risk factor P value
Type of valve (biologic or mechanical) .49
NYHA class .39
Preoperative anemia* .35
No. of preoperative bleeding events .48
No. of preoperative units of blood transfused .61
Location of angiodysplasia .001
Preoperative valve area .3
NYHA, New York Heart Association. *Anemia defined as hemoglobin less than
10 mg/dL.
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jejunum in 14 patients (25%). Multiple sites of angiodys-
plasia were found in 12 patients (21%). All synchronous le-
sions were associated with angiodysplasia of the right colon
and with various other locations in the GI tract. In 7 of the
12 patients, the location of the synchronous lesion was the
duodenum, with the other lesions scattered throughout the
rest of the GI tract. After intestinal angiodysplasia was diag-
nosed, 24 patients (42%) underwent an intervention to con-
trol the bleeding locally. Of these 24 patients, 13 had
cauterization of the lesion, 7 had laser treatment, 3 had
a portion of bowel resected, and 1 underwent selective
mesenteric embolization. Despite these treatments, all pa-
tients had recurrent GI bleeding before later undergoing
AVR.
The mean age of patients at the time of AVR was 74 10
years. Most patients had New York Heart Association func-
tional class II (25 patients) or class III (28 patients) heart
failure. Before AVR, the mean ejection fraction was 58%
 11%, the mean preoperative aortic valve gradient was
62  24 mm Hg, and the mean valve area was 0.7  0.3
cm2. The aortic valve was congenitally bicuspid in 12 pa-
tients (21%). The native valve was replaced with a biopros-
thesis in 47 patients and with a mechanical valve in 10
patients. Concomitant coronary revascularization was per-
formed in 18 patients (32%). Two patients died before hos-
pital discharge, but after 1987, there were no perioperative
deaths; 1 patient required an intra-aortic balloon pump, and
the rest had an uncomplicated postoperative course. Overall
survival was 93% at 1 year postoperatively and 59% at 5
years.
At follow-up (median, 4.4 years; range, 0.1–15 years),
45 patients (79%) had no further bleeding and appeared
cured. For the 12 patients experiencing recurrent GI bleed-
ing after AVR (overall risk, 21%), the mean  SD number
of bleeding episodes was reduced from 4.7  7 per
patient-year to 1.9  2 per patient-year (Figure 1), and
only 3 patients required additional transfusions for GI
bleeding. In the 12 patients with persistent GI bleeding af-
ter AVR, additional GI studies revealed the persistence of
angiodysplasia in 6 patients, Crohn disease in 1 patient,
and a gastric Dieulafoy ulcer in 1 patient; in the other 4
patients, no source of bleeding was identified. All patients114 The Journal of Thoracic and Cardiovascular Surgwho had recurrent bleeding due to intestinal angiodyspla-
sia had lesions in the right colon or duodenum. The only
risk factor for recurrence was location of the angiodyspla-
sia (Table 4). Among patients who received bioprostheses,
the risk of recurrence was 15% versus 50% for patients
with mechanical prostheses (P ¼ .49).DISCUSSION
The association between aortic valve stenosis and GI
bleeding was initially described 60 years ago. In a letter
to The New England Journal of Medicine, Heyde described
his experience with ‘‘at least 10 patients with calcific aortic
stenosis who had massive GI bleeding for which we could
discover no cause.’’ Heyde made the diagnosis of aortic
valve stenosis on the basis of a palpable systolic thrill and
a harsh systolic murmur that was transmitted widely to
the neck or back. Although some early sporadic reports
linked aortic valve stenosis with GI bleeding,20 the first de-
tailed case descriptions were not published until the
1970s,21-23 which was when the condition of aortic valve
stenosis associated with GI bleeding or intestinal
angiodysplasia achieved eponymous status.
In an earlier report from our clinic, King and colleagues15
identified 91 patients with unexplained GI bleeding and
concomitant aortic valve stenosis. They categorized the pa-
tients into 3 groups: 40 patients who had no operation, 37
patients who underwent abdominal exploration or bowel re-
section for bleeding, and 16 patients who underwent AVR
(2 of whom also had an abdominal procedure and 2 of
whom died intraoperatively). All 40 patients who did not
undergo any operation continued to bleed and required re-
peat blood transfusions. Of the 37 patients who underwent
abdominal operation, 35 had persistent bleeding. Of the
16 patients who underwent AVR, only 1 patient had contin-
ued bleeding postoperatively, which consisted of bleeding
gingiva secondary to an elevated prothrombin time. King
and colleagues concluded that for patients with unexplained
GI bleeding and concomitant aortic valve stenosis, AVR of-
fered a likely cure. Our findings confirm AVR as an effec-
tive treatment for not only severe aortic valve stenosis but
also bleeding from intestinal angiodysplasia.ery c July 2012
FIGURE 2. Postoperative bleeding events by valve type. After AVR in 57
patients, bleeding resolved in 45 patients. Five of 10 patients with mechan-
ical valves and 7 of 47 patients with bioprosthetic valves had recurrent
bleeding.
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bowel has led to the recognition of angiodysplasia as a rela-
tively common cause of GI bleeding, although some clini-
cians have questioned its association with aortic valve
disease.24 It is now understood that the prevalence of intes-
tinal angiodysplasia, like that of aortic valve stenosis, in-
creases with age. Our findings are in agreement with this
assumption, in light of the clinical characteristics of our pa-
tients, whose mean age was 74 10 years. Although angio-
dysplasia can occur anywhere in the GI tract, the right colon
is the most common site,25 which was true for our patients
with aortic valve stenosis.
Localization of the culprit lesion in patients with angio-
dysplasia can be difficult. Our group of 57 patients had a to-
tal of 161 diagnostic procedures before AVR, for an average
of 2.8 procedures per patient. Thirty-five patients (61%) un-
derwent both an upper endoscopy and a colonoscopy.
Among the 14 patients who had angiodysplasia of the jeju-
num, all underwent upper endoscopy, colonoscopy, and ad-
ditional diagnostic testing before the source of GI bleeding
could be identified. Likewise, the 12 patients with multifo-
cal angiodysplasia had multiple diagnostic studies per-
formed to identify bleeding sites.
In patients with Heyde syndrome, therapeutic strategies
aimed at treating the bleeding intestinal angiodysplasia of-
ten produce only short-term success. Blind right colec-
tomy was advised in the 1960s for patients who had
presumed Heyde syndrome with persistent idiopathic GI
bleeding.26 With the advent of endoscopy, less invasive
measures can be used to control bleeding angiodysplasia,
including electrocautery and laser treatment with the
neodymium:yttrium-aluminum-garnet laser. Despite initial
success with these endoscopic techniques, long-term fol-
low-up shows that recurrent bleeding occurs in at least
one third of patients.27
Twenty-four (42%) of our 57 patients had an intervention
before AVR that was aimed at stopping the GI bleeding; of
these 24 patients, 3 underwent bowel resection. Despite
such efforts, all 57 patients continued to bleed before under-
going AVR. In contrast, after AVR, 45 (79%) of the 57 pa-
tients had no further bleeding, and among the 12 (21%) who
did experience recurrent bleeding (5 with mechanical
valves and 7 with bioprosthetic valves), the frequency of
such events was reduced by half (Figure 2).
CONCLUSIONS
The association between aortic valve stenosis and GI
bleeding seems well established, and our findings demon-
strated that AVR was curative in more than 75% of patients
and substantially reduced bleeding episodes in patients who
had recurrence. Thus, GI bleeding due to angiodysplasia
may be considered an indication for AVR in patients with
hemodynamically important aortic valve stenosis. Although
rates of recurrent bleeding did not differ substantially byThe Journal of Thoracic and Catype of prosthetic valve (mechanical or bioprosthetic), the
higher risk of bleeding in patients with mechanical valves
who are receiving warfarin makes the bioprosthesis valve
the valve type of choice for most patients. Other conditions
(eg, ventricular assist devices,28 hypertrophic obstructive
cardiomyopathy,29 and congenital heart defects30) have
the propensity to create high shear forces and may contrib-
ute to GI bleeding by the same mechanism.
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